FI953793L - Morfoliinijohdannainen - Google Patents

Morfoliinijohdannainen Download PDF

Info

Publication number
FI953793L
FI953793L FI953793A FI953793A FI953793L FI 953793 L FI953793 L FI 953793L FI 953793 A FI953793 A FI 953793A FI 953793 A FI953793 A FI 953793A FI 953793 L FI953793 L FI 953793L
Authority
FI
Finland
Prior art keywords
morpholine derivative
morpholine
derivative
Prior art date
Application number
FI953793A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI953793A0 (fi
FI953793A7 (fi
Inventor
Mitsuo Fujii
Takayuki Suzuki
Satoshi Hayashibe
Shin-Ichi Tsukamoto
Shin-Ichi Yatsugi
Tokio Yamaguchi
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of FI953793A0 publication Critical patent/FI953793A0/fi
Publication of FI953793A7 publication Critical patent/FI953793A7/fi
Publication of FI953793L publication Critical patent/FI953793L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
FI953793A 1993-02-10 1994-02-08 Morfoliinijohdannainen FI953793L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4569193 1993-02-10
JP24014793 1993-09-27
PCT/JP1994/000186 WO1994018182A1 (fr) 1993-02-10 1994-02-08 Derive de morpholine

Publications (3)

Publication Number Publication Date
FI953793A0 FI953793A0 (fi) 1995-08-10
FI953793A7 FI953793A7 (fi) 1995-08-10
FI953793L true FI953793L (fi) 1995-08-10

Family

ID=26385743

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953793A FI953793L (fi) 1993-02-10 1994-02-08 Morfoliinijohdannainen

Country Status (18)

Country Link
US (1) US5521180A (fr)
EP (1) EP0684237B1 (fr)
KR (1) KR100302819B1 (fr)
CN (1) CN1042028C (fr)
AT (1) ATE187448T1 (fr)
AU (1) AU670675B2 (fr)
CA (1) CA2155183A1 (fr)
DE (1) DE69422021T2 (fr)
DK (1) DK0684237T3 (fr)
ES (1) ES2142397T3 (fr)
FI (1) FI953793L (fr)
GR (1) GR3032816T3 (fr)
HU (1) HU220383B (fr)
NO (1) NO305170B1 (fr)
PT (1) PT684237E (fr)
TW (1) TW397829B (fr)
UA (1) UA41350C2 (fr)
WO (1) WO1994018182A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
CA2422055A1 (fr) * 2000-09-11 2002-03-21 Sepracor, Inc. Ligands pour les recepteurs de monoamine et transporteurs, et procedes d'utilisation de ces derniers
US7294637B2 (en) * 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
JP2005034165A (ja) * 2002-06-26 2005-02-10 Mu-Hyun Cho マット一体型のストーンベッド
AU2005260955A1 (en) * 2004-07-14 2006-01-19 Astellas Pharma Inc. Agent for promoting the recovery from dysfunction after the onset of central neurological disease
TW200846003A (en) * 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
TW200846002A (en) 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
WO2009128057A2 (fr) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Produits psycho-pharmaceutiques
KR101165996B1 (ko) 2010-04-23 2012-07-18 주식회사 녹십자 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives
JPS5283773A (en) * 1976-01-01 1977-07-12 Yamanouchi Pharmaceut Co Ltd Novel indene derivative
JPS52111580A (en) * 1976-03-15 1977-09-19 Yamanouchi Pharmaceut Co Ltd Novel indene derivatives and salts thereof
JPS55113717A (en) * 1979-02-24 1980-09-02 Yamanouchi Pharmaceut Co Ltd Antidepressive drug
JPS61145119A (ja) * 1984-12-19 1986-07-02 Yamanouchi Pharmaceut Co Ltd 脳障害による精神症状の改善，治療剤
AU5136385A (en) * 1984-12-20 1986-07-17 Medicament P.F 2-arylalkyloxymethyl-morpholine derivatives
GB2177085A (en) * 1985-06-18 1987-01-14 Ici Plc Fungicidal compounds and compositions

Also Published As

Publication number Publication date
EP0684237B1 (fr) 1999-12-08
FI953793A0 (fi) 1995-08-10
CA2155183A1 (fr) 1994-08-18
ATE187448T1 (de) 1999-12-15
DE69422021D1 (en) 2000-01-13
US5521180A (en) 1996-05-28
HU9502359D0 (en) 1995-10-30
KR100302819B1 (ko) 2001-11-22
WO1994018182A1 (fr) 1994-08-18
DK0684237T3 (da) 2000-05-08
ES2142397T3 (es) 2000-04-16
NO953118L (no) 1995-10-10
PT684237E (pt) 2000-04-28
NO953118D0 (no) 1995-08-09
HU220383B (hu) 2002-01-28
FI953793A7 (fi) 1995-08-10
GR3032816T3 (en) 2000-06-30
EP0684237A1 (fr) 1995-11-29
CN1117729A (zh) 1996-02-28
DE69422021T2 (de) 2000-07-13
UA41350C2 (uk) 2001-09-17
EP0684237A4 (fr) 1996-02-14
AU670675B2 (en) 1996-07-25
TW397829B (en) 2000-07-11
CN1042028C (zh) 1999-02-10
HUT72674A (en) 1996-05-28
AU5980094A (en) 1994-08-29
NO305170B1 (no) 1999-04-12

Similar Documents

Publication Publication Date Title
FI942252A7 (fi) Piperatsiinijohdannaisia
FI943976A7 (fi) 5-aryyli-indolijohdannaiset
FI954829L (fi) Aroyylipiperidiinijohdannaiset
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
FI954579L (fi) Uusia pednisolonijohdannaisia
FI945674L (fi) Substituoidut 2beta-morfoliini-androstaanijohdannaiset
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
FI942444A7 (fi) Terahydropyraanijohdannaisia
FI943885L (fi) Penaami-johdannaiset
FI944044L (fi) Fenyylialkanoliamiinijohdannaiset
FI971227A7 (fi) Pyramidinyylipyratsolijohdannaisia
EE9600011A (et) Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid
FI953793L (fi) Morfoliinijohdannainen
NO965233D0 (no) Deacetoksytaksol-derivat
DE69527786D1 (de) Diaminomethyliden-derivate
NO970144L (no) Trifluormetylkinolinkarboksylsyre-derivat
FI931610A7 (fi) Piperatsiinijohdannaisia
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
DE69510792D1 (de) Naphtochinonderivate
DE59509209D1 (de) Diphenyloxazolin-derivate
FI955026A7 (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
FI963122A7 (fi) Karbamoyylimetyyliureajohdannaiset
DE69400388D1 (de) Cyclohexendiolderivate
DE69427775D1 (de) Dimethylfurancarboxamilid-derivat
NO951573D0 (no) Tiadiazinon-derivater